🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
FUL
$FULC
🔒 US EquitiesFulcrum Therapeutics Inc
AVG HISTORICAL GAP
-0.11%
MAX GAP RECORD
-18.85%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $FULC
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$FULC
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (21:00)) |
-0.80%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE) |
+0.00%
|
| Apr 27, 2026 Earnings Release 2026-04-27 (BEFORE OPEN) |
-4.53%
|
| Feb 24, 2026 Earnings Release 2026-02-24 (BEFORE OPEN) |
-11.39%
|
| Oct 29, 2025 Earnings Release 2025-10-29 (BEFORE OPEN) |
-2.80%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN) |
-1.92%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE) |
-0.26%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (BEFORE OPEN) |
-3.24%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.7%
Bullish Gaps (7)
Bearish Gaps (6)
Neutral / Flat (2)
📖 Intelligence Summary
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E….
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗